does semaglutide cause ulcers Severe reflux oesophagitis caused by repeated vomiting due to glucagon-like peptide-1 receptor agonist Ozempic and GLP-1 Drugs: Risk

In January 2026, the MHRA approved a higher dose of Wegovy, 7.2 mg per week, for adults with obesity (BMI of 30 or above)

The hope with this latest approval for heart health is that more insurance companies will provide greater coverage, which would be a good first step. In late March, the Centers for Medicare and Medicaid Services issued new guidance saying Medicare Part D plans can start covering anti-obesity drugs if they are also approved for an added health benefit, such as heart health.

Both healthcare professionals and people with diabetes mentioned taking smaller doses by manually dialing the dose down based on the number of clicks on the pen

Inside interoception: The hidden sense of how you feel inside Researchers are decoding how signals move between body and brain, with implications for how we understand and treat conditions from obesity to anxiety